Cargando…
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
Long-term multiple myeloma therapy by immunomodulatory drugs (IMiDs) raises the question of management of adverse effects. The aim of this study is to assess the impact of an educational session for patients on the acquisition of knowledge to manage hematologic and thromboembolic adverse effects of...
Autores principales: | Périchou, Juliette, Ranchon, Florence, Herledan, Chloé, Huot, Laure, Larbre, Virginie, Carpentier, Isabelle, Lazareth, Anne, Karlin, Lionel, Beny, Karen, Vantard, Nicolas, Schwiertz, Vérane, Caffin, Anne Gaelle, Baudouin, Amandine, Sesques, Pierre, Brisou, Gabriel, Ghesquières, Hervé, Salles, Gilles, Rioufol, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717911/ https://www.ncbi.nlm.nih.gov/pubmed/33275634 http://dx.doi.org/10.1371/journal.pone.0243309 |
Ejemplares similares
-
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
por: Collomb, Bastien, et al.
Publicado: (2022) -
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
por: Ranchon, Florence, et al.
Publicado: (2011) -
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
por: Bourbon, Estelle, et al.
Publicado: (2022) -
Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients
por: Baudouin, Amandine, et al.
Publicado: (2023) -
Hypersensitivity to oxaliplatin: clinical features and risk factors
por: Parel, Marie, et al.
Publicado: (2014)